MarketCapExport financials
iBio (IBIO)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
iBio Income Statement 2026-2010 | IBIO
Brief overview of profit and loss at iBio
The figures are compared over a five-year interval. According to figures from iBio, revenue changed from $1.6 million to $400 thousand over five years. The total change was −75.6%, with a CAGR of approximately −24.6%. The business finished the period with a smaller revenue base.
The five-year EBITDA result moved by −54%: from −$11.8 million to −$18.1 million. Operating profitability strengthened faster than the scale of sales. Comparing the endpoints gives EBITDA margins of −718.1% and −4529.5%. A lower EBITDA share weakens the quality of the result.
The net financial result changed from −16.4 million dollars to −18.4 million dollars. Profitability deteriorated further over the five years.
Conclusion
The indicators point to a weaker financial profile. Caution is warranted because of a narrow EBITDA buffer, a declining EBITDA margin and a softer top-line trend. Investors should continue to monitor margins, costs, and earnings quality.
Annual Income Statement iBio
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
142 M | 60.6 M | 7.55 M | 177 K | 22.2 M | - | 294 M | 13.1 M | 8.72 M | 27.6 M | 50.2 M | 46.5 M | 24.6 M | 24.7 M | 46.6 M | 83.3 M | - |
Shares |
104 M | 10.5 M | 3.83 M | 612 K | 8.72 M | 7.82 M | 62.8 M | 18.9 M | 10.6 M | 8.91 M | 8.1 M | 7.15 M | 6.3 M | 4.94 M | 3.95 M | 3.1 M | - |
Historical Prices |
1.36 | 5.77 | 1.97 | 0.29 | 2.54 | 0.48 | 1.6 | 0.28 | 0.87 | 1.7 | 4 | 6 | 4.8 | 5.8 | 6.8 | 8.5 | 5.45 K |
Net Income |
-33 M | -18.4 M | -24.9 M | -65 M | -50.3 M | -23.2 M | -16.4 M | -17.6 M | -16.1 M | -14.5 M | -9.76 M | -6.62 M | -3.67 M | -6.2 M | -5.68 M | -12.1 M | - |
Revenue |
100 K | 400 K | 225 K | - | 1.88 M | 2.37 M | 1.64 M | 2.02 M | 444 K | 394 K | 948 K | 1.85 M | 205 K | 1.01 M | 1.28 M | 520 K | - |
Cost of Revenue |
- | - | - | - | 216 K | 1.46 M | 703 K | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | 2.17 M | 909 K | - | - | - | - | - | - | - | - | 1.28 M | 520 K | - |
Operating Income |
-35.1 M | -18.6 M | -16.6 M | -29.3 M | -29.7 M | -31.1 M | -14 M | -15.8 M | -14.2 M | -14.3 M | -9.89 M | -6.67 M | -3.84 M | -6.67 M | -9.33 M | -9.65 M | - |
Interest Expense |
- | - | - | 83 K | 1.41 M | 2.45 M | 2.47 M | 1.9 M | 1.92 M | 1.93 M | 807 K | - | - | 90 K | 63 K | 50.5 K | - |
EBITDA |
-34.6 M | -18.1 M | -16 M | -28.7 M | -27.4 M | -30.6 M | -11.8 M | -14 M | -12.5 M | -12.6 M | -8.95 M | -6.3 M | -3.48 M | -6.33 M | -9 M | -9.28 M | - |
Operating Expenses |
35.2 M | 19 M | 16.9 M | 29.3 M | 31.6 M | 32 M | 15.6 M | 17.8 M | 14.7 M | 14.7 M | 10.8 M | 8.52 M | 4.04 M | 7.67 M | 10.6 M | 10.2 M | - |
General and Administrative Expenses |
10.6 M | 10.7 M | 11.7 M | 19 M | 21.8 M | 22 M | 12.4 M | 12.3 M | 10.7 M | 10.6 M | 7.68 M | 5.02 M | 4.2 M | 4.24 M | 5.62 M | 7.09 M | - |
All numbers in USD currency
Quarterly Income Statement iBio
| 2026-Q4 | 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
- | 120 M | 99.1 M | 53 M | 99.1 M | 53 M | 19.3 M | 9.86 M | 9.13 M | 8.63 M | 8.62 M | 3.71 M | 1.86 M | 1.2 M | 1.02 M | 659 K | 490 K | 8.84 M | 8.73 M | 8.72 M | 8.72 M | 8.72 M | 8.72 M | 216 M | 188 M | 162 M | 188 K | 162 K | 36.9 K | 21.9 K | 36.9 K | 21.9 K | 18.7 K | 17.9 K | 18.7 M | 17.9 M | 9.66 M | 9.18 M | 96.6 M | 91.9 M | 89.1 M | 89.1 M | 89.1 M | 89.1 M | 77.3 M | 77.3 M | 77.3 M | 77.3 M | 71 M | 65.9 M | 68.4 M | 65.6 M | 64 M | 56.7 M | 64 M | 56.7 M | 47.8 M | 47.8 M | 47.8 M | 47.8 M | 32.4 M | 32.4 M | 32.4 M | 32.4 M |
Net Income |
- | -7.73 M | -8.99 M | -5.72 M | -8.99 M | -5.72 M | - | -4.86 M | -4.36 M | -3.99 M | - | -3.17 M | -8.21 M | -5.75 M | - | -7.29 M | -33.6 M | -18.1 M | -51.7 M | -12.4 M | -11.9 M | -8.94 M | -20.9 M | -7.66 M | -8.13 M | -7.53 M | -8.13 M | -7.53 M | -3.76 M | -4.46 M | -3.76 M | -4.46 M | -4.47 M | -4.4 M | -4.47 M | -4.4 M | -3.9 M | -3.83 M | -3.9 M | -3.83 M | -3.23 M | -3.06 M | -3.23 M | -3.06 M | -2.25 M | -1.8 M | -2.25 M | -1.8 M | -1.65 M | -1.41 M | -1.65 M | -1.41 M | -1.62 M | 379 K | -1.62 M | 379 K | -1.07 M | -2.05 M | -1.07 M | -2.05 M | -1.6 M | 383 K | -1.6 M | 383 K |
Revenue |
- | 100 K | - | 100 K | - | 100 K | - | - | 200 K | - | - | - | - | 50 K | - | - | - | - | - | 1.8 M | 168 K | 84 K | 84 K | 765 K | 705 K | 410 K | 705 K | 410 K | 314 K | 108 K | 314 K | 108 K | 651 K | 45 K | 651 K | 78 K | 153 K | 122 K | 275 K | 37 K | 75 K | 135 K | 75 K | 135 K | 134 K | 160 K | 134 K | 160 K | 367 K | 819 K | 367 K | 819 K | - | - | - | - | - | 390 K | 390 K | 390 K | 234 K | 320 K | 234 K | 320 K |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 48 K | 113 K | 40 K | 153 K | 493 K | 211 K | 107 K | - | 86 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.9 M | 55 K | 171 K | 226 K | 272 K | 494 K | 303 K | - | 10 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | -8.36 M | -9.44 M | -5.95 M | -9.44 M | -5.95 M | - | -4.88 M | -4.42 M | -4.11 M | - | -3.63 M | -4.5 M | -5.1 M | - | -6.17 M | -10.6 M | -7.64 M | -18.2 M | -6.79 M | -7.23 M | -5.22 M | -12.5 M | -7.2 M | -7.54 M | -6.92 M | -7.54 M | -6.92 M | -3.16 M | -3.86 M | -3.16 M | -3.86 M | -4.02 M | -3.95 M | -4.02 M | -3.95 M | -3.43 M | -3.36 M | -3.43 M | -3.36 M | -3.32 M | -3.15 M | -3.32 M | -3.15 M | -2.25 M | -1.81 M | -2.25 M | -1.81 M | -1.67 M | -1.42 M | -1.67 M | -1.42 M | -1.64 M | 240 K | -1.64 M | 240 K | -1.7 M | -1.81 M | -1.7 M | -1.81 M | -2.67 M | -2.33 M | -2.67 M | -2.33 M |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | 52 K | 34 K | 26 K | - | 35 K | 31 K | - | 31 K | 250 K | 328 K | 609 K | 937 K | 612 K | 615 K | 614 K | 615 K | 614 K | 615 K | 620 K | 615 K | 620 K | 476 K | 476 K | 476 K | 476 K | 479 K | 480 K | 479 K | 480 K | 483 K | 483 K | 483 K | 483 K | - | - | - | - | - | 3 K | - | - | - | - | - | 15 K | 17 K | 15 K | 17.5 K | 15.4 K | 16.8 K | 9.58 K | 16.8 K | 9.58 K |
EBITDA |
- | -7.95 M | -9.18 M | -5.83 M | -9.44 M | -5.83 M | - | -4.87 M | -4.41 M | -3.99 M | - | -3.62 M | -4.49 M | -4.94 M | - | -6.16 M | -10.5 M | -7.36 M | -17.8 M | -6.67 M | -7.11 M | -4.92 M | -11.6 M | -7.08 M | -7.43 M | -6.83 M | -7.43 M | -6.83 M | -3.08 M | -3.79 M | -3.02 M | -3.79 M | -3.84 M | -3.77 M | -3.84 M | -3.59 M | -3.09 M | -3.02 M | -3.09 M | -3.02 M | -3 M | -2.83 M | -3 M | -2.83 M | -2.25 M | -1.81 M | -2.25 M | -1.81 M | -1.58 M | -1.42 M | -1.66 M | -1.42 M | -1.55 M | 241 K | -1.64 M | 241 K | -1.61 M | -1.73 M | -1.53 M | -1.73 M | -2.59 M | -2.25 M | -2.51 M | -2.25 M |
Operating Expenses |
- | 8.36 M | 9.44 M | 6.05 M | 9.44 M | 6.05 M | - | 4.88 M | 4.62 M | 4.11 M | - | 3.63 M | 4.5 M | 5.15 M | - | 6.17 M | 10.6 M | 7.64 M | 18.2 M | 8.59 M | 7.23 M | 5.31 M | 12.5 M | 7.48 M | 8.04 M | 7.23 M | 8.25 M | 7.33 M | 3.47 M | 3.96 M | 3.47 M | 3.96 M | 4.67 M | 4 M | 4.67 M | 4 M | 3.58 M | 3.48 M | 3.58 M | 3.48 M | 3.4 M | 3.29 M | 3.4 M | 3.29 M | 2.39 M | 1.97 M | 2.39 M | 1.97 M | 2.03 M | 2.24 M | 2.03 M | 2.24 M | 1.64 M | -240 K | 1.64 M | -240 K | 1.7 M | 2.2 M | 1.7 M | 2.2 M | 2.91 M | 2.65 M | 2.91 M | 2.65 M |
General and Administrative Expenses |
- | 5.11 M | 5.16 M | 2.5 M | 5.16 M | 2.5 M | - | 2.97 M | 2.74 M | 2.8 M | - | 2.72 M | 2.96 M | 3.55 M | - | 3.52 M | 7.79 M | 5.09 M | 12.9 M | 5.32 M | 5.37 M | 4.18 M | 9.55 M | 5.31 M | 5.66 M | 5.36 M | 5.81 M | 5.57 M | 2.58 M | 2.99 M | 2.58 M | 2.99 M | 3.39 M | 2.87 M | 3.39 M | 2.87 M | 2.59 M | 2.5 M | 2.59 M | 2.5 M | 2.35 M | 2.47 M | 2.35 M | 2.47 M | 1.68 M | 1.42 M | 1.68 M | 1.42 M | 1.3 M | 1.05 M | 1.3 M | 1.05 M | 1.05 M | 949 K | 1.05 M | 949 K | 1.04 M | 1.02 M | 1.04 M | 1.02 M | 1.75 M | 1.19 M | 1.75 M | 1.19 M |
All numbers in USD currency
The income statement is one of the three key financial reports of a company iBio (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
USA
Russia
Israel
Canada
Schweiz
China
Britain
Irlanda
